The third and fourth stops of our Neuroprotection Demonstration Application Promotion Program were successfully held in Beijing on January 17, 2026, and in Jinan, Shandong, on January 23, 2026.
Under the theme “Exploring Neuroprotection Strategies,” the two events brought together clinical professionals, medical institutions, academic representatives, industry partners and other stakeholders. We exchanged views on neuroprotection, electrophysiology innovation, clinical application and medical-device cooperation.
The Beijing event focused on the demonstration application of intraoperative neuroprotection in support of precision and safety in surgery. It was held alongside the 2025 Annual Academic Conference of the Microsurgery Branch of the Beijing Medical Association and a seminar on new developments in microsurgery.
The event provided an opportunity to discuss intraoperative neurophysiological monitoring, clinical needs and the role of electrophysiology technologies in relevant surgical settings. We also exchanged views with clinical and academic representatives on the continued development of neuroprotection strategies and their application in surgical practice.
The Jinan event focused on the demonstration application of intraoperative neuroprotection. It was held alongside the 2026 Shandong Medical Device Industry Annual Conference and the Jinan stop of the 76th National Touring Investment Promotion Summit organized by Yizhao Tianxia Group.
Under the theme “Neuroprotection, Clinical Access and Collaboration for Shared Growth,” we presented our development in neurophysiology and discussed electrophysiology applications and medical-device cooperation with medical institutions, channel partners and other stakeholders.
The event connected clinical exchange with practical cooperation opportunities and provided a platform for discussing the development, implementation and service of integrated electrophysiology solutions.
Across the Beijing and Jinan events, we presented our key cooperation portfolio for 2026. The portfolio covered outpatient, intraoperative and inpatient application settings and followed an integrated equipment + consumables + software + service approach.
The portfolio included:
Our intraoperative neurophysiological monitoring system was the first Category III intraoperative neuromonitoring device in China with completely independent intellectual property rights. It featured multimodal combined monitoring and dual-screen visualization, and supported multidimensional neurophysiological signal monitoring, including SEP, MEP, EMG and EEG.
The system was developed to support neural monitoring in general surgery, thyroid and breast surgery, neurosurgery and other specialties. Its dedicated consumables were designed for compatibility with the monitoring system and supported a continuous clinical workflow.
Our wireless surface EMG biofeedback system was developed from our technical experience in wireless monitoring. By removing the constraints of traditional cables, the system enabled real-time acquisition and wireless transmission of electromyographic signals.
The system was applied across rehabilitation assessment, sports medicine and pain management scenarios. Its streamlined operating design supported efficient use, while its dedicated disposable consumables followed sterile-use requirements. The system was also designed to address different clinical needs across primary healthcare institutions and large tertiary hospitals.
Our polysomnography system was selected for the recommended list of the Shanghai Artificial Intelligence Medical Device “Major Project Open Competition,” or “Jiebang Guaishu,” initiative.
The system combined flexible sensing technology with multimodal signal-processing algorithms. It captured multidimensional physiological data, including EEG, EOG and EMG, throughout sleep cycles and supported the assessment of sleep-related conditions such as sleep apnea syndrome.
Its wireless design supported patient monitoring, while specialized consumables and intelligent analysis software helped create an integrated workflow for sleep monitoring and analysis.
The Jinan roadshow also introduced our cooperation model for eligible partners. The model combined dedicated consumables with equipment support, including equipment provided at no additional charge or at a preferential price together with trial consumables.
This approach was designed to support partner evaluation and cooperation around integrated electrophysiology solutions. It also enabled us to discuss equipment applications, consumable use, service capabilities and long-term cooperation with regional partners.
The Jinan event included a themed forum on strengthening core competitiveness in the medical-device sector amid changes in the healthcare environment. The forum covered cooperation models, customer value, service capabilities and the practical requirements of medical-device development and implementation.
During the forum，Drawing on nearly three decades of experience in the medical-device industry, Mr. Mao Shunming, Chairman of NCC Electrophysiology, shared the company’s approach to building core competitiveness. He said:
“The core challenge for hospitals lies in balancing equipment investment with operating returns. To address this challenge, we have developed innovative products and business models that combine low-margin or zero-margin hardware with consumables-based charging. This model is designed to help hospitals generate returns from surgical procedures and significantly increase their willingness to use the equipment.
At the same time, we have focused on the neuroprotection sector, leveraging product differentiation and a relatively low level of market competition. Our related solution has been successfully implemented and validated in thyroid surgery. We will continue to place customer value and profitability at the center of our development, supported by a comprehensive service system, to build and strengthen our core competitiveness.”
We remained committed to advancing electrophysiology technology and product development while exploring new opportunities for collaboration between industry and clinical practice.
NCC Electrophysiology was recognized as a national-level Specialized and Sophisticated “Little Giant” enterprise. Our consumables subsidiary, Shanghai Yingshou Medical Devices Co., Ltd., was recognized as a Shanghai-level Specialized and Sophisticated “Little Giant” enterprise.
Two of our self-developed products—the intraoperative nerve stimulation monitoring device and the 256-channel event-related potential digital EEG system for auxiliary cognitive assessment—were included in the Shanghai Innovative Medical Device Catalogue.
These achievements reflected our continued investment in independent research and development, product innovation and coordinated development across electrophysiology equipment and consumables.
The Beijing and Jinan events marked further progress in our Neuroprotection Demonstration Application Promotion Program. Through professional exchange and regional activities, we continued to engage with clinical and industry partners on neuroprotection, electrophysiology technology and clinical application pathways.
We remained focused on understanding clinical needs, developing medical-device solutions and strengthening cooperation between industry and clinical practice. Through continued exchange and collaboration, we will keep exploring responsible approaches to electrophysiology innovation and clinical translation.
Copyright © NCC Medical Co., Ltd. - Privacy policy
EN